Cabazitaxel (CBZ) activity in men with metastatic castration resistant prostate cancer (mCRPC) with and without DNA damage repair (DDR) defects

Affiliation auteurs!!!! Error affiliation !!!!
TitreCabazitaxel (CBZ) activity in men with metastatic castration resistant prostate cancer (mCRPC) with and without DNA damage repair (DDR) defects
Type de publicationJournal Article
Year of Publication2020
AuteursAldea M., Lam L., C. Perez L, Saint-Ghislain M., G. Mescam G, Flechon A., Roubaud G., Barthelemy P., Ricci F., Priou F., Neviere Z.M, Beaufils M., Helissey C., Ratta R., Pobel C., E. Marcos C, Thiery-Vuillemin A., Baciarello G., Orillard E., Fizazi K.
JournalANNALS OF ONCOLOGY
Volume31
PaginationS510
Date PublishedSEP
Type of ArticleMeeting Abstract
ISSN0923-7534
DOI10.1016/j.annonc.2020.08.873